Sign In
Buy QTRX
$3.22
-0.270 (-7.74%)
At Close: Jun 23, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quanterix Corporation - QTRX
04:15pm, Tuesday, 04'th Feb 2025
NEW YORK , Feb. 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX). Such investors are advised
NEW YORK , Feb. 4, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Quanterix Corporation
The Schall Law Firm Invites Shareholders With Losses In Quanterix Corporation To Join A Securities Fraud Investigation
11:00am, Monday, 03'rd Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix
NEW YORK, NY / ACCESS Newswire / February 2, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Quanterix
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix
The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Quanterix Corporation For Securities Fraud
11:00am, Saturday, 01'st Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix
NEW YORK, Feb. 01, 2025 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Quanterix Corporat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quanterix Corporation - QTRX
10:00am, Saturday, 01'st Feb 2025
NEW YORK, NY / ACCESS Newswire / February 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX). Such investors a
NEW YORK, NY / ACCESS Newswire / January 31, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Quanterix
LOS ANGELES, CA / ACCESS Newswire / January 31, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix
ROSEN, A TOP RANKED LAW FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation – QTRX
05:00pm, Thursday, 30'th Jan 2025
NEW YORK, NY / ACCESS Newswire / January 30, 2025 / WHY: \Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Quanterix
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quanterix Corporation - QTRX
12:00pm, Thursday, 30'th Jan 2025
NEW YORK, NY / ACCESS Newswire / January 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX). Such investors a
The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Quanterix Corporation For Securities Fraud
11:00am, Thursday, 30'th Jan 2025
LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix
NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Quanterix Corporat
NEW YORK , Jan. 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Quanterix Corpo
